Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2988-2989

  Cuisset, Thomas ^a,b,c   Cayla, Guillaume ^d   Quilici, Jacques ^a,b,c   Pankert, Mathieu ^a,b,c   Deharo, Pierre ^a,b,c   Bonnet, Guillaume ^a,b,c   Grosdidier, Charlotte ^a,b,c   Beguin, Shirley ^e   Morange, Pierre ^a,b,c   Bonnet, Jean Louis ^a,b,c   Alessi, Marie Christine ^a,b,c  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d NÎMES UNIVERSITY HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Acute coronary syndrome; Prasugrel; PRI VASP; Stable CAD

Indexed keywords

PIPERAZINE DERIVATIVE; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE;

ACUTE CORONARY SYNDROME; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG EFFECTS; FEMALE; HUMAN; MALE; MIDDLE AGED; OFF LABEL DRUG USE; THROMBOCYTE;

ACUTE CORONARY SYNDROME; BLOOD PLATELETS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OFF-LABEL USE; PIPERAZINES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES;

EID: 84885642214     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.052     Document Type: Article

References (9)

1. M.E. Bertrand, H.J. Rupprecht, P. Urban, A.H. Gershlick, and F.T. Investigators Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation 102 2000 624 629
2. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
3. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
4. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 36 2009 1045 1057
5. L. Bonello, L. Camoin-Jau, and S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411
6. G. Parodi, B. Bellandi, and F. Venditti Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel Am J Cardiol 109 2012 214 218
7. G. Cayla, J.S. Hulot, and S.A. O'Connor Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis JAMA 306 2011 1765 1774
8. J.P. Collet, T. Cuisset, and G. Rangé Bedside monitoring to adjust antiplatelet therapy for coronary stenting N Engl J Med 367 2012 2100 2109
9. T. Cuisset, M. Loosveld, P.E. Morange, J. Quilici, P.J. Moro, N. Saut, B. Gaborit, C. Castelli, S. Beguin, C. Grosdidier, L. Fourcade, J.L. Bonnet, and M.C. Alessi CYP2C19*2 and*17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome JACC Cardiovasc Interv 5 12 2012 1280 1287